Iqvia Holdings IQV
NYSE IQV
$262.13 +0.62 (+0.24%)
As of: Aug 27, 2026 · 3:59 PM EDT

Iqvia Holdings (IQV) Cash from Financing Activities (2012 - 2026)

Iqvia Holdings (IQV) posted Cash from Financing Activities of -$214.0 million for Q2 2026, up 50.58% sequentially from -$433.0 million in Q1 2026, and down 247.59% YoY from $145.0 million in Q2 2025.

Iqvia Holdings (IQV) Cash from Financing Activities (2012 - 2026) Analysis & Trends

Iqvia Holdings has reported Cash from Financing Activities for 15 years, with the latest figure at -$214.0 million in Q2 2026.

  • Quarterly Cash from Financing Activities fell 247.59% year-over-year to -$214.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$684.0 million (down 9.44% YoY) and the FY2025 annual result came in at -$150.0 million, up 82.92% from the prior year.
  • Cash from Financing Activities rose to -$214.0 million in Q2 2026 per IQV's latest filing, from -$433.0 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $535.0 million in Q4 2025 and troughed at -$572.0 million in Q3 2025.
  • A 5-year average of -$132.6 million and a median of -$168.5 million in 2022 frame the typical range for Cash from Financing Activities.
  • The sharpest annual moves came in 2023 and 2024: Cash from Financing Activities soared 427.59% in 2023, then sank 373.68% in 2024.
  • Over 5 years, Cash from Financing Activities stood at -$193.0 million in 2022, then tumbled by 117.62% to -$420.0 million in 2023, then rose by 10.71% to -$375.0 million in 2024, then soared by 242.67% to $535.0 million in 2025, then sank by 140.0% to -$214.0 million in 2026.
  • According to Business Quant data, Cash from Financing Activities over the past three periods registered -$214.0 million, -$433.0 million, and $535.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn -1.57 Bn
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn 7.27 Bn
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn 12.21 Mn
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn -144.00 Mn
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn -214.00 Mn
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn -325.19 Mn
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn -129.00 Mn
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn -317.75 Mn
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn -919.90 Mn
10 Quest Diagnostics 27.10 Bn 26.47 Bn 1.03 Bn -229.00 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -214.00 Mn
Jun 30, 2026 -214.00 Mn
Mar 31, 2026 -433.00 Mn
Mar 31, 2026 -433.00 Mn
Dec 31, 2025 535.00 Mn
Dec 31, 2025 535.00 Mn
Sep 30, 2025 -572.00 Mn
Sep 30, 2025 -572.00 Mn
Jun 30, 2025 145.00 Mn
Jun 30, 2025 145.00 Mn
Mar 31, 2025 -258.00 Mn
Mar 31, 2025 -258.00 Mn
Dec 31, 2024 -375.00 Mn
Dec 31, 2024 -375.00 Mn
Sep 30, 2024 -137.00 Mn
Sep 30, 2024 -137.00 Mn
Jun 30, 2024 -260.00 Mn
Jun 30, 2024 -260.00 Mn
Mar 31, 2024 -106.00 Mn
Mar 31, 2024 -106.00 Mn